MASHINIi

Universe Pharmaceuticals Inc.

UPC.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Universe Pharmaceuticals Inc. is a pharmaceutical company focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine (TCM) products in China. Their product portfolio includes a variety of TCM drugs, dietary supplements, and other healthcare products. The company...Show More

Ethical Profile

Mixed.

Universe Pharmaceuticals Inc. has faced regulatory scrutiny, receiving a Nasdaq notification for failing to file its annual report, which violates Nasdaq Listing Rule 5250(c)(1). Environmentally, the company recorded a DitchCarbon score of 20, placing it lower than 94% of its industry, with no publicly available data on emissions or participation in reduction initiatives. Critics also point to potential animal welfare concerns, as traditional Chinese medicine (TCM) often incorporates animal-derived ingredients, and operations in China may involve less stringent animal testing regulations. The company does have whistleblower and anti-corruption policies in place, though enforcement details are limited.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Universe Pharmaceuticals Inc on Better Health for All.

Fair Money & Economic Opportunity

0

Universe Pharmaceuticals Inc. is a pharmaceutical company, and the 'Fair Money & Economic Opportunity' value is designed for financial institutions. The company does not offer lending, deposit, or other financial services to consumers.

1
Therefore, all KPIs related to financial products, services, and customer financial outcomes are not applicable, as there is no evidence of UPC.US engaging in activities that lend, insure, move, or store money for consumers.
2

Fair Pay & Worker Respect

0

No evidence was found in the provided articles regarding any of the KPIs for Fair Pay & Worker Respect. The articles focus solely on Universe Pharmaceuticals Inc.'s Nasdaq delisting notices and failure to file its annual report, which are not relevant to living wage, CEO-median pay ratio, collective bargaining, safety incident rates, pay equity, worker engagement, turnover, labor violations, insecure contracts, or health insurance coverage.

1

Fair Trade & Ethical Sourcing

0

No specific quantitative data is available regarding Universe Pharmaceuticals Inc.'s fair trade and ethical sourcing practices.

1
The provided articles do not offer metrics on the percentage of spend covered by fair-trade certifications, supplier audit frequency, substantiated forced or child labor incidents, supply chain traceability coverage, remediation speed for violations, ethical clause coverage in supplier contracts, share of spend on high-risk materials, or procurement budget directed to diverse suppliers for UPC.US.
2
While general discussions about sustainable sourcing in the Traditional Chinese Medicine (TCM) industry are present, these do not provide company-specific metrics.
3

Honest & Fair Business

-40

The company has a whistleblower policy that outlines reporting procedures, confidentiality, and protection against retaliation, but there is no evidence of independent investigation processes.

1
An anti-corruption policy is in place, explicitly addressing the Foreign Corrupt Practices Act (FCPA) and prohibiting bribery and kickbacks, but details on enforcement mechanisms and training effectiveness are limited.
2
The company received a staff determination notice from Nasdaq on February 19, 2025, for failing to file its Annual Report (Form 20-F) for the fiscal year ended September 30, 2024, violating Nasdaq Listing Rule 5250(c)(1).
3
The company is also before a Hearings Panel for non-compliance with Listing Rule 5550(a)(2).
4

Kind to Animals

0

No evidence available to assess Universe Pharmaceuticals Inc on Kind to Animals.

No War, No Weapons

0

No evidence available to assess Universe Pharmaceuticals Inc on No War, No Weapons.

Planet-Friendly Business

0

No specific data points or publicly available information were found in the provided articles for any of the Planet-Friendly Business KPIs. The articles primarily focus on financial performance and administrative announcements, with one article explicitly stating a lack of publicly available data for all relevant environmental metrics, including Scope 1, 2, and 3 emissions, SBTi-aligned targets, renewable energy usage, water use, green building certifications, waste diversion, EU taxonomy alignment for capex, lifecycle impact analysis, recycled to virgin ratio, carbon offset quality, climate-positive initiatives, supply chain climate transparency, supplier SBTi targets, biodiversity efforts, deforestation policy, environmental compliance violations, environmental impact assessments, net-zero target year, TCFD alignment, climate scenario analysis, stranded assets transparency, water from stressed basins, packaging CO2 reduction, climate justice initiatives, just transition programs, or climate adaptation financing.

1

Respect for Cultures & Communities

0

No evidence available to assess Universe Pharmaceuticals Inc on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess Universe Pharmaceuticals Inc on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific sustainability data, including information related to waste management, product recyclability, packaging, or waste reduction initiatives, is available for UPC.US in the provided articles. One article explicitly states that sustainability data is currently unavailable for the company.

1

Own Universe Pharmaceuticals Inc?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.